SCHEMBL29409968

SCHEMBL29409968

CCC(F)(F)c1cccc(NC(=O)C(=NO)C(C)=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ ACSS2 Q9NR19 1/20 0.42
▸ MAPT P10636 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ GFER P55789 1/20 0.41
▸ XBP1 P17861 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HTT P42858 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22658194 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TP53ACSS2MAPT
SCHEMBL22658193 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TP53ACSS2MAPT
SCHEMBL24027994 0.87 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2TP53MAPTMEN1
SCHEMBL24028391 0.87 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2TP53MAPTMEN1
SCHEMBL29409971 0.86 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TP53ACSS2MAPT
SCHEMBL22678605 0.86 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TP53ACSS2MAPT
SCHEMBL24028135 0.81 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2TP53MAPTMEN1
SCHEMBL30213098 0.81 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2TP53MAPTMEN1
SCHEMBL24027845 0.80 LMNA (0.46) ALDH1A1SMN1; SMN2TP53MAPTMEN1
SCHEMBL30255658 0.80 LMNA (0.46) ALDH1A1SMN1; SMN2TP53MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3969439-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2022-03-23 — — EP disclosed
Send feedback